Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARNA | NUVL | BPMC | ||
| Company | Arena Pharmaceuticals | Nuvalent Inc Cl A | Blueprint Medicines Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 99.97 | 93.71 | 96.78 | ||
| High | 100.00 | 95.27 | 98.34 | ||
| Low | 99.97 | 92.36 | 94.11 | ||
| Last | 99.99 | 94.93 | 94.15 | ||
| Change | +0.06 | +2.20 | -2.47 | ||
| % Change | +0.06% | +2.37% | -2.56% | ||
| Volume | 5,718,500 | 419,500 | 663,500 | ||
| 20-Day Average Volume | 1,676,465 | 464,315 | 758,350 | ||
| Previous Close | 99.93 | 92.73 | 96.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 94.81 | 91.35 | 93.65 | ||
| 20-Day Raw Stochastic | 99.86% | 86.66% | 58.91% | ||
| 20-Day Relative Strength | 75.07% | 52.36% | 52.40% | ||
| Weighted Alpha | -14.40 | +40.73 | +24.68 | ||
| Today's Opinion | 100% Buy | 56% Buy | 48% Sell | ||
| Previous Opinion | 100% Buy | 56% Buy | 16% Sell | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.34% since 03/03/22 | +9.27% since 11/15/24 | +6.16% since 11/15/24 | ||
| Low | 93.54 on 03/07/22 | 85.38 on 11/18/24 | 88.05 on 11/18/24 | ||
| High | 100.00 on 03/10/22 | 95.27 on 11/22/24 | 98.34 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +6.37% since 02/10/22 | -7.39% since 10/22/24 | +8.88% since 10/22/24 | ||
| Low | 92.85 on 02/22/22 | 85.38 on 11/18/24 | 80.68 on 10/29/24 | ||
| High | 100.00 on 03/10/22 | 98.01 on 10/23/24 | 103.55 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +100.22% since 12/10/21 | +14.37% since 08/22/24 | +0.68% since 08/22/24 | ||
| Low | 89.03 on 01/25/22 | 80.80 on 09/12/24 | 80.68 on 10/29/24 | ||
| High | 100.00 on 03/10/22 | 113.51 on 09/16/24 | 103.55 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +68.36% since 09/10/21 | +35.96% since 05/22/24 | -8.33% since 05/22/24 | ||
| Low | 48.12 on 12/06/21 | 64.26 on 05/31/24 | 80.68 on 10/29/24 | ||
| High | 100.00 on 03/10/22 | 113.51 on 09/16/24 | 121.90 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,165,283 | 6,588,745 | 6,137,883 | ||
| Shares Outstanding, K | 61,659 | 71,053 | 63,526 | ||
| Annual Sales | 50,000 | 0 | 249,380,000 | ||
| Annual Net Income | -616,430,000 | -126,220,000 | -506,980,000 | ||
| Last Quarter Sales | 50,000 | 0 | 128,180,000 | ||
| Last Quarter Net Income | -155,610,000 | -84,350,000 | -56,280,000 | ||
| 60-Month Beta | 0.55 | 1.33 | 0.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.54 on 02/23/22 | -1.28 on 11/12/24 | -0.89 on 10/30/24 | ||
| Latest Earnings Date | 05/04/22 | 11/12/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||